started · updated
Stryker reports strong Q2 2026 earnings as shares drop 9%
U.S. medical‑device maker Stryker posted robust second‑quarter 2026 results. Revenue for the quarter was $6.6 billion, topping analysts' $6.58 billion estimate, while total sales for the first half of fiscal 2026 reached $12.609 billion, a 5% constant‑currency rise. The medical‑surgery and neurotechnology segment generated $3.6 billion, up 9.7% year‑over‑year but missing the $3.72 billion forecast. The orthopedics segment posted $3.0 billion in sales, a 9.1% increase that beat the $2.72 billion expectation. Adjusted earnings per share were $3.69, exceeding the $3.49 consensus. Stryker narrowed its adjusted annual profit outlook to $14.95‑$15.10 per share. Despite the beat, the stock fell about 9% in extended trading. The MedSurg and neurotechnology segment contributed $6.832 billion, a 6.5% rise, and the company’s operating margin was reported at 26.7% in a separate European release.
Entities
Juan Carlos Botzotz · Kevin Lobo · MedSurg and Neurotechnology segment · Medical surgery and neurotechnology unit · Orthopedics segment · Stryker Corp · Stryker Corporation
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 2 SOURCES] For the first half of fiscal 2026, Stryker's total sales were $12.609 billion, a 5% constant‑currency increase over 2025. www.pharmabiz.net
- [● 6 SOURCES] The orthopedics segment saw a 9.1% increase in sales to $3.0 billion, beating analysts' expectations of $2.72 billion. mix929.com · wdez.com · jack1065.com · kelo.com · wxerfm.com · +1 more
- [● 2 SOURCES] The MedSurg and neurotechnology segment generated $6.832 billion in the first half of fiscal 2026, a 6.5% constant‑currency increase. www.pharmabiz.net
- [● 6 SOURCES] Stryker's shares fell about 9% in extended trading after the earnings release. mix929.com · wdez.com · jack1065.com · kelo.com · wxerfm.com · +1 more
- [● 6 SOURCES] Stryker reported total revenue of $6.6 billion for the quarter, above analysts' estimate of $6.58 billion. mix929.com · wdez.com · jack1065.com · kelo.com · wxerfm.com · +1 more
- [● 6 SOURCES] Adjusted earnings per share for the quarter were $3.69, surpassing the consensus estimate of $3.49. mix929.com · wdez.com · jack1065.com · kelo.com · wxerfm.com · +1 more
- [● 7 SOURCES] Stryker narrowed its adjusted annual profit forecast to $14.95‑$15.10 per share, from a prior range of $14.90‑$15.10. mix929.com · wdez.com · jack1065.com · kelo.com · wxerfm.com · +1 more
- [● 6 SOURCES] Sales at Stryker's medical surgery and neurotechnology unit rose 9.7% to $3.6 billion, missing analysts' estimate of $3.72 billion. mix929.com · wdez.com · jack1065.com · kelo.com · wxerfm.com · +1 more